Washington: The US Food and Drug Administration granted emergency authorization Friday for the use of Pfizer and Moderna Covid-19 vaccines in the youngest children, the final age group awaiting immunization in most countries.

The agency authorized Moderna's two-dose vaccine for children aged six months to five years, and three doses of Pfizer's shots for those between six months and four years old.